Denon Kitt v. United States

Court of Appeals for the Third Circuit·Decided November 26, 2018·No. 18-1869·Unpublished

Opinion

ALD-033 NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

No. 18-1869

DENON KITT,

Appellant

v.

UNITED STATES OF AMERICA

On Appeal from the United States District Court for the Middle District of Pennsylvania (D.C. Civ. No. 3-15-cv-01115)

District Judge: Robert D. Mariani

Submitted on a Motion for Summary Affirmance Pursuant to Third Circuit LAR 27.4 and I.O.P. 10.6

November 15, 2018

Before: MCKEE, SHWARTZ, and BIBAS, Circuit Judges

(Opinion filed: November 26, 2018)

OPINION*

PER CURIAM Denon Kitt appeals from an order of the District Court granting summary judgment to the United States of America. For the reasons that follow, we will summarily affirm.

* This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not constitute binding precedent.

Kitt, a federal inmate, sued the United States (“the Government”) under the Federal Tort Claims Act (“FTCA”), alleging that he contracted latent tuberculosis (“TB”) when he was negligently exposed to another inmate, who was suffering from active TB, at the United States Penitentiary in Waymart, Pennsylvania (“USP Canaan”). Kitt alleged that the Federal Bureau of Prisons failed to take reasonable precautions with respect to the infected inmate, by isolating him instead of placing him on Kitt’s unit, and that, as a result, he contracted latent TB. He sought $5,000,000 in damages. After taking Kitt’s deposition, the Government moved for summary judgment, which Kitt opposed. The Magistrate Judge issued a Report and Recommendation. Kitt submitted Objections. The District Court then overruled Kitt’s objections and awarded summary judgment to the Government. In an order entered on April 6, 2018, the District Court denied Kitt’s timely motion for reconsideration.

Kitt appeals pro se, and the United States has moved for summary affirmance.

Kitt has responded to the motion, and his response has been treated as his Informal Brief.

We will summarily affirm because no substantial question is presented by this appeal, Third Circuit LAR 27.4 and I.O.P. 10.6. Summary judgment is appropriate “if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). The moving party has the initial burden of identifying evidence that shows an absence of a genuine issue of material fact, Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986). The District Court is required to view the facts in the light most favorable to the non-moving party and make all reasonable inferences in his favor, see Armbruster v. Unisys Corp., 32 F.3d 768, 777

(3d Cir. 1994). Furthermore, credibility determinations on material issues cannot be made in the context of a motion for summary judgment, nor may a District Court weigh the evidence. See Petruzzi’s IGA Supermarkets, Inc. v. Darling-Delaware Co., Inc., 998 F.2d 1224, 1230 (3d Cir. 1993).

On the other hand, the nonmoving party may not rest on mere allegations or denials, Fed. R. Civ. Pro. 56(e)(2), (3). See also Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 256 (1986). Kitt was required, in opposing the Government’s motion for summary judgment, to designate specific facts by use of affidavits, depositions, admissions, or answers to interrogatories showing that there was a genuine issue for trial. See Fed. R. Civ. P. 56(c) (setting forth requirements for supporting or opposing party’s assertion that a fact cannot be or is genuinely disputed). Ultimately, “[w]here the record taken as a whole could not lead a rational trier of fact to find for the non-moving party, there is no genuine issue for trial.” Matsushita Electric Industrial Co. v. Zenith Radio Corp., 475 U.S. 574, 587 (1986).

The BOP policy for infectious disease management, including tuberculosis, is set forth in Program Statement 6190.04. This program statement provides that, before an inmate is transferred between BOP institutions, he must be medically cleared for tuberculosis. Specifically, there must be no evidence of medical complaints or symptoms associated with tuberculosis within the past 30 days, and the inmate must have a baseline negative chest x-ray result if the tuberculin skin test is positive.

The summary judgment record establishes the following undisputed facts.

Kimberly Bucklaw, R.N., the Quality Improvement Infection Prevention and Control

Coordinator at USP Canaan, directs activities to identify and control infectious disease at USP Canaan. Her review of the medical records of the infected inmate disclosed that he was transferred into USP Canaan from Estill Federal Correctional Institute in South Carolina in May, 2011. On arrival, the medical documentation indicated that this inmate, while previously treated for latent tuberculosis, was asymptomatic for active tuberculosis. The inmate’s Intra-System Transfer Form indicated that he had a chest x-ray performed on April 20, 2011, which was negative for active TB. Accordingly, he was not isolated from other inmates. More than a year later, on August 15, 2012, a new x-ray of the carrier inmate’s chest revealed a mass in his left upper chest, but the physician specifically stated in his note that he did not see any evidence of tuberculosis in the chest at that time.

On January 18, 2013, a pre-operative chest x-ray revealed an unspecified mass in the inmate’s left lung. On June 26, 2013, the inmate had a follow-up examination following a chest x-ray in which a hilar mass of the left lung was observed; a CT scan was ordered to rule out cancer. On August 12, 2013, the inmate was transferred to Wayne Memorial Hospital. An administrative note in the inmate’s medical record on August 13, 2013 indicated that he had been placed in isolation. On August 19, 2013, prison medical staff received positive confirmation that the inmate had active TB. In her Report of Consultation, Dr. Rosita Liu confirmed the diagnosis of active TB and made two observations which Kitt now, among other things, relies upon: that the inmate had a “known lung mass since 2010;” and that he “was exposed to tuberculosis in 1994 and had six months of therapy.”

The infected inmate was returned to USP Canaan on November 14, 2013 and immediately placed in isolation and separated from all inmates, where he remained until he was released. In the meantime, Bucklaw took action to identify and treat any potential cases of tuberculosis within USP Canaan. Kitt, who had no prior history of tuberculosis exposure, received several tuberculin skin tests. His skin tests on August 19 and October 8, 2013 were negative, but a repeat test on October 23, 2013, was positive. Kitt was asymptomatic for the active strain of TB and his chest x-rays were negative. He underwent a course of preventative care, including treatment with Isoniazid, and has since remained asymptomatic for active TB.

Free access — add to your briefcase to read the full text and ask questions with AI

Denon Kitt v. United States, (3d Cir. 2018).

Denon Kitt v. United States (Denon Kitt v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Armbruster v. Unisys Corp.
32 F.3d 768 (Third Circuit, 1994)
Hamil v. Bashline
392 A.2d 1280 (Supreme Court of Pennsylvania, 1978)
Martin v. Evans
711 A.2d 458 (Supreme Court of Pennsylvania, 1998)